The factors included in the multivariate analysis were age, tumor stage, T category of the stage, lymph node metastasis, histologic grade, mitotic count, and the expression of HER2, PR, FAM83H-Nu, FAM83h-Cy, and PD1. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.